Medipure Pharmaceuticals

Medipure is a biopharmaceutical incubator focused on treating critical diseases on a global scale, striving to provide new first in class medications.

[Medipure Pharmaceuticals @MedipureP]

ICYMI: "MP-40X is a unique therapeutic platform that comprises a series of endocannabinoid targeting molecules and is a fantastic addition to our portfolio of intellectual property," stated Dr. Nihar Pandey, Medipure's Chief Scientific Officer. Read here: https://t.co/51qX4zNYi1

[Medipure Pharmaceuticals @MedipureP]

Dr. John Maynard discusses Medipure and the opportunity to help a huge population with our proprietary prescription drugs. Watch here. #Medipure #Pharmaceuticals #Science #Research #Healthcare

[Medipure Pharmaceuticals @MedipureP]

Medipure is proud of its esteemed Scientific Advisory Board comprised of Dr. Xia Zhang, Dr. Neil Solomon, Dr. Gerald Zamponi & Dr. Ognjen Brborovic who are all global leaders & experts in their fields. Read about them: https://t.co/zrByi4KPKv #Medipure #Pharmaceuticals #Science

[Medipure Pharmaceuticals @MedipureP]

CEO Boris Weiss discussing his excitement for market potentials and how Medipure can help patients but also how bright the horizon is for the company. Watch here. #Medipure #Pharmaceuticals #Healthcare #Science #Research

[Medipure Pharmaceuticals @MedipureP]

ICYMI: Treatment for Inflammatory Skin Conditions Added to Innovative Pharmaceutical Company’s Portfolio of Prescription Medications – Read more: https://t.co/1i5DbCPQ8F #Medipure #Pharmaceuticals #Healthcare #Science #Research #Psoriasis

[Medipure Pharmaceuticals @MedipureP]

"I think it is fair to say that over the last decade there has been more interest in the endocannabinoid system than any other system in our body and understanding this system has generated an awareness of therapeutic potentials in many health-related areas." Dr. John Maynard

[Medipure Pharmaceuticals @MedipureP]

Our core products target specific disease areas including pain management, mood disorders/anxiety, nausea, appetite, oncology, arthritis, dermatology and fatty liver disease (NASH). Watch here: https://t.co/rDK2n3WY7G #Medipure #Pharmaceuticals #Healthcare #Science #Research

[Medipure Pharmaceuticals @MedipureP]

Happy Labour Day to our Canadian friends and family & Happy Labor Day to our friends and family in the U.S. #Medipure #Pharmaceuticals #Healthcare #Science #Research

[Medipure Pharmaceuticals @MedipureP]

#FlashbackFriday As part of Medipure’s global development and global market penetration, CEO Boris Weiss discusses expansion into Croatia. Watch here: https://t.co/g8uoIKjWI9 #Medipure #Pharmaceuticals #Science #ClinicalTrials #Croatia

[Medipure Pharmaceuticals @MedipureP]

One prevalent area these days for many in our society is anxiety, which is a result of a combination of biological, psychological, and other individual factors. Read more about it: https://t.co/DNPSFqXJce #Medipure #Pharmaceuticals #Healthcare #Science #Research #Anxiety

[Medipure Pharmaceuticals @MedipureP]

CEO Boris Weiss discusses Medipure’s pharmaceutical drugs and the importance of patient affordability and true science. Watch here. #Medipure #Pharmaceuticals #Healthcare #PatientAffordability #Science

[Medipure Pharmaceuticals @MedipureP]

#FlashbackFriday 2018’s Grand Opening of Medipure’s Labs in Burnaby, British Columbia. “A new wave and truly a coming out for Medipure.” Watch here: https://t.co/u8naIjGf6K #Medipure #Pharmaceuticals #Science #Research #Canada

[Medipure Pharmaceuticals @MedipureP]

Watch Dr. John Maynard discuss the Endocannabinoid System and how he depends on science. #Medipure #Pharmaceuticals #Science #Research #EndocannabinoidSystem

[Medipure Pharmaceuticals @MedipureP]

Medipure has a world-class leadership team behind its ‘first in class’ drugs. Learn about this diverse, exceptional group of leaders here: https://t.co/MYeAwbigvc #Medipure #Pharmaceuticals #Science #Research #Leadership

[Medipure Pharmaceuticals @MedipureP]

"Our main focus is to develop drugs which are safe and that can act on lower doses so that there are no side effects of those drugs," says Dr. Nihar Pandey, Medipure’s Chief Scientific Officer. Watch here. #Medipure #Pharmaceuticals #Science #Research

[Medipure Pharmaceuticals @MedipureP]

Dr. John Maynard discusses the advantages of Medipure's prescription drugs for doctors and patients. #Medipure #Pharmaceuticals #Research #Science #GoodbyeOpioids

[Medipure Pharmaceuticals @MedipureP]

ICYMI: "Conducting clinical and pharmaceutical development trials is an estimated US$127-billion-a-year industry globally, and Canada should get in on it," says Boris Weiss, CEO of Medipure Pharmaceuticals Inc. Read more here: https://t.co/Mg6djKjOK8 #Medipure #Research #Canada

[Medipure Pharmaceuticals @MedipureP]

#FlashbackFriday CEO Boris Weiss discussing expansion into India: “Will be a lead for our clinical trials in India and will be a conduit for penetrating both the Indian and Asian marketplace.” Watch here: https://t.co/i6CAYQq9mB #Medipure #Pharmaceuticals #ClinicalTrials

[Medipure Pharmaceuticals @MedipureP]

Clinical research is medical research involving people. When one volunteers to take part in clinical research, doctors & researchers learn more about disease & improve healthcare for people in the future. Read more about #clinicaltrials here: https://t.co/2MeA3k85rJ #Medipure

[Medipure Pharmaceuticals @MedipureP]

We are constantly looking for new out-of-the-box ideas and collaborative partnerships in the key disease areas. Our collaboration policy is designed accordingly to foster long-term relationships with both academic and private collaborative partnerships. Let's connect! #Medipure